Cell Line : YD-15
Cellosaurus Index : CVCL_8930
Cellosaurus ID : YD-15
CTRP2 Name
: YD15
CCLE Name
: YD15_SALIVARY_GLAND
Cancer Type : salivary_gland
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| YD-15 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AA-COCF3 | CTRP2 | 0.0081 | 17.0000 |
|
| YD-15 | ABT737 | CTRP2 | 0.0011 | 18.0000 |
|
| YD-15 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | AT7867 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| YD-15 | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Bexarotene | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BIBR-1532 | CTRP2 | 0.0081 | 130.0000 |
|
| YD-15 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | blebbistatin | CTRP2 | 0.0041 | 66.0000 |
|
| YD-15 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BMS-345541 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BMS-536924 | CTRP2 | 0.0011 | 18.0000 |
|
| YD-15 | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| YD-15 | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| YD-15 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 4.2000 |
|
| YD-15 | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K02492147 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K16130065 | CTRP2 | 0.0020 | 8.3000 |
|
| YD-15 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K27986637 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| YD-15 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K71781559 | CTRP2 | 0.0041 | 66.0000 |
|
| YD-15 | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K79669418 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K92856060 | CTRP2 | 0.0010 | 0.5200 |
|
| YD-15 | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD-K99584050 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| YD-15 | BRD4770 | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | BRD55319 | CTRP2 | 0.0011 | 18.0000 |
|
| YD-15 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD6430 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Cabozantinib | CTRP2 | 0.0320 | 66.0000 |
|
| YD-15 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| YD-15 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| YD-15 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| YD-15 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| YD-15 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| YD-15 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| YD-15 | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| YD-15 | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| YD-15 | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| YD-15 | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| YD-15 | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| YD-15 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Daporinad | CTRP2 | 0.0000 | 0.2600 |
|
| YD-15 | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| YD-15 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Entinostat | CTRP2 | 0.0160 | 33.0000 |
|
| YD-15 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| YD-15 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| YD-15 | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| YD-15 | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | Fulvestrant | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| YD-15 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Gemcitabine | CTRP2 | 0.0010 | 8.3000 |
|
| YD-15 | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| YD-15 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | isoliquiritigenin | CTRP2 | 0.0010 | 8.3000 |
|
| YD-15 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| YD-15 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| YD-15 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0081 | 66.0000 |
|
| YD-15 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | KU 0060648 | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | L-685458 | CTRP2 | 0.0011 | 18.0000 |
|
| YD-15 | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | LE-135 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Linsitinib | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| YD-15 | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| YD-15 | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| YD-15 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Navitoclax | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| YD-15 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | neopeltolide | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | neratinib | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| YD-15 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NSC632839 | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| YD-15 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | NVP-TAE684 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| YD-15 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | OSI-930 | CTRP2 | 0.0020 | 17.0000 |
|
| YD-15 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| YD-15 | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| YD-15 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | pifithrin-alpha | CTRP2 | 0.0071 | 120.0000 |
|
| YD-15 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | PRIMA-1MET | CTRP2 | 0.0010 | 17.0000 |
|
| YD-15 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| YD-15 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| YD-15 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Rapamycin | CTRP2 | 0.0010 | 8.3000 |
|
| YD-15 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0130 | 220.0000 |
|
| YD-15 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| YD-15 | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 42.0000 |
|
| YD-15 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| YD-15 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0730 | 150.0000 |
|
| YD-15 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| YD-15 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| YD-15 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| YD-15 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| YD-15 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| YD-15 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Sepantronium bromide | CTRP2 | 0.0001 | 1.0000 |
|
| YD-15 | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| YD-15 | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SKI-II | CTRP2 | 0.0041 | 66.0000 |
|
| YD-15 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| YD-15 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| YD-15 | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Staurosporine | CTRP2 | 0.0001 | 3.3000 |
|
| YD-15 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| YD-15 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| YD-15 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| YD-15 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| YD-15 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| YD-15 | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| YD-15 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| YD-15 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| YD-15 | Tubastatin A | CTRP2 | 0.0320 | 33.0000 |
|
| YD-15 | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| YD-15 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| YD-15 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| YD-15 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0020 | 2.1000 |
|
| YD-15 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | XL765 | CTRP2 | 0.0020 | 33.0000 |
|
| YD-15 | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| YD-15 | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| YD-15 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| YD-15 | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC